CN115245528A - 一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 - Google Patents
一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 Download PDFInfo
- Publication number
- CN115245528A CN115245528A CN202210025971.6A CN202210025971A CN115245528A CN 115245528 A CN115245528 A CN 115245528A CN 202210025971 A CN202210025971 A CN 202210025971A CN 115245528 A CN115245528 A CN 115245528A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- eye
- health product
- cats
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 46
- 241000282472 Canis lupus familiaris Species 0.000 title claims abstract description 23
- 241000282326 Felis catus Species 0.000 title claims abstract description 23
- 208000030533 eye disease Diseases 0.000 title claims abstract description 23
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 22
- 230000035764 nutrition Effects 0.000 title claims abstract description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 34
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 32
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 32
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 19
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 19
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 19
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 17
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 17
- 239000011718 vitamin C Substances 0.000 claims abstract description 17
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 16
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 16
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 16
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 16
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 16
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 16
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 16
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 16
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 16
- 239000001168 astaxanthin Substances 0.000 claims abstract description 16
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 16
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008518 lycium barbarum polysaccharide Substances 0.000 claims abstract description 16
- 229960003080 taurine Drugs 0.000 claims abstract description 16
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 16
- 239000011719 vitamin A Substances 0.000 claims abstract description 16
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 16
- 239000011720 vitamin B Substances 0.000 claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 claims abstract description 16
- 239000011709 vitamin E Substances 0.000 claims abstract description 16
- 229940045997 vitamin a Drugs 0.000 claims abstract description 16
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 16
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 16
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 16
- 102000040350 B family Human genes 0.000 claims abstract description 7
- 108091072128 B family Proteins 0.000 claims abstract description 7
- 240000000785 Tagetes erecta Species 0.000 claims abstract 7
- 235000013336 milk Nutrition 0.000 claims description 15
- 239000008267 milk Substances 0.000 claims description 15
- 210000004080 milk Anatomy 0.000 claims description 15
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 235000010208 anthocyanin Nutrition 0.000 claims description 3
- 239000004410 anthocyanin Substances 0.000 claims description 3
- 229930002877 anthocyanin Natural products 0.000 claims description 3
- 150000004636 anthocyanins Chemical group 0.000 claims description 3
- 235000012680 lutein Nutrition 0.000 claims description 3
- 239000001656 lutein Substances 0.000 claims description 3
- 229960005375 lutein Drugs 0.000 claims description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 3
- 125000002635 lutein group Chemical group 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 3
- 210000001508 eye Anatomy 0.000 abstract description 56
- 210000001525 retina Anatomy 0.000 abstract description 20
- 230000003647 oxidation Effects 0.000 abstract description 14
- 238000007254 oxidation reaction Methods 0.000 abstract description 14
- 210000000608 photoreceptor cell Anatomy 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 9
- 210000004204 blood vessel Anatomy 0.000 abstract description 8
- 210000004087 cornea Anatomy 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 7
- 210000001328 optic nerve Anatomy 0.000 abstract description 7
- 239000013078 crystal Substances 0.000 abstract description 6
- 230000004483 macular pigment optical density Effects 0.000 abstract description 6
- 230000003204 osmotic effect Effects 0.000 abstract description 5
- 230000007850 degeneration Effects 0.000 abstract description 4
- 210000000653 nervous system Anatomy 0.000 abstract description 4
- 230000002980 postoperative effect Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000006318 protein oxidation Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003750 conditioning effect Effects 0.000 abstract 2
- 235000013384 milk substitute Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 21
- 241000736851 Tagetes Species 0.000 description 11
- 210000000695 crystalline len Anatomy 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 4
- 102000004330 Rhodopsin Human genes 0.000 description 4
- 108090000820 Rhodopsin Proteins 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 230000000474 nursing effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000004561 lacrimal apparatus Anatomy 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,属于犬猫保健领域,一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,所述保健品至少由万寿菊提取物、蓝莓提取物、虾青素、玉米黄素、牛磺酸、枸杞多糖、维生素A、维生素C、维生素E、维生素B族、酵母粉、代乳粉等组分制成,它可以实现,调养宠物眼睛细胞组织、神经***,减少术后养护和眼部退化性情况,减少眼睛中的水晶体氧化,加强眼睛中的细小血管韧性,调养眼角膜、视神经、视网膜和减少自由基的伤害,减少视网膜氧化和感光细胞的损伤,减少黄斑色素密度和紫外线的影响,调节眼部晶体渗透压、加强感光细胞、减少晶体中的蛋白质氧化等作用,减少眼疾的发生。
Description
技术领域
本发明涉及犬猫保健领域,更具体地说,涉及一种为犬猫眼部组织提供营养和预防部分眼疾的保健品。
背景技术
宠物是为了精神的目的而家养的动物,一般为了消除孤寂、陪伴而家养,在所有动物类宠物中,普遍流行的主要为狗和猫;
猫狗在家养的过程中由于环境、食物、不同年龄阶段等综合情况容易产生疾病。对于眼部疾病,现有技术除了手术或者眼药水(抗细菌或病毒)等治疗手段,目前市场上还没有一款专门针对眼部而提供营养并预防犬猫眼部疾病的产品,为此我们结合宠物眼部各器官对精准营养需要,而提出一种为犬猫眼部组织提供营养和预防部分眼疾的保健品。
发明内容
1.要解决的技术问题
针对现有技术中存在的问题,本发明的目的在于提供一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,它可以实现,调养宠物眼睛细胞组织、神经***,减少术后养护和眼部退化性情况,减少眼睛中的水晶体氧化,加强眼睛中的细小血管韧性,调养眼角膜、视神经、视网膜和减少自由基的伤害,减少视网膜氧化和感光细胞的损伤,减少黄斑色素密度和紫外线的影响,调节眼部晶体渗透压、加强感光细胞、减少晶体中的蛋白质氧化等作用,减少眼疾的发生。
2.技术方案
为解决上述问题,本发明采用如下的技术方案。
一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,所述保健品至少由万寿菊提取物、蓝莓提取物、虾青素、玉米黄素、牛磺酸、枸杞多糖、维生素A、维生素C、维生素E、维生素B族、酵母粉、代乳粉等组分制成。
进一步的,所述保健品各组份按照以下重量份配比:
万寿菊提取物50份~65份、蓝莓提取物15份~22份、虾青素8份~12 份、玉米黄素16份~25份、牛磺酸16份~23份、枸杞多糖40份~70份、维生素A7.5份~15份、维生素C3份~8份、维生素E3份~7份、维生素B 族6份~12份、酵母粉30份~45份、代乳粉500份~600份。
进一步的,所述保健品各组份按照以下重量份配比:
万寿菊提取物50份、蓝莓提取物15份、虾青素8份、玉米黄素16份、牛磺酸16份、枸杞多糖40份、维生素A7.5份、维生素C3份、维生素E3份、维生素B族6份、酵母粉30份、代乳粉500份。
进一步的,所述保健品各组份按照以下重量份配比:
万寿菊提取物60份、蓝莓提取物20份、虾青素10份、玉米黄素20份、牛磺酸20份、枸杞多糖60份、维生素A10份、维生素C5份、维生素E5份、维生素B族10份、酵母粉40份、代乳粉525份。
进一步的,所述保健品各组份按照以下重量份配比:
万寿菊提取物65份、蓝莓提取物22份、虾青素12份、玉米黄素25份、牛磺酸23份、枸杞多糖70份、维生素A15份、维生素C8份、维生素E7份、维生素B族12份、酵母粉45份、代乳粉600份。
进一步的,所述蓝莓提取物为花青素。
进一步的,所述万寿菊提取物为叶黄素。
进一步的,所述保健品还包括有以下重量份配比的组份:
防腐剂1份、抗氧化剂1份和诱食剂40份。
3.有益效果
相比于现有技术,本发明的优点在于:
(1)本方案能够调养宠物眼睛细胞组织和神经***,减少术后养护和眼部退化性情况的发生。
(2)本方案能够减少眼睛中的水晶体氧化,加强眼睛中的细小血管韧性,调养眼角膜、视神经、视网膜和减少自由基的伤害。
(3)本方案能够减少视网膜氧化和感光细胞的损伤,以及黄斑色素密度和紫外线的影响,调节眼部晶体渗透压、加强感光细胞、减少晶体中的蛋白质氧化等作用,从而可减少眼疾的发生。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述;显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例,基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明为一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,所述保健品至少由万寿菊提取物、蓝莓提取物、虾青素、玉米黄素、牛磺酸、枸杞多糖、维生素A、维生素C、维生素E、维生素B族、酵母粉、代乳粉等组分制成。
其中,所述万寿菊提取物为叶黄素,是眼睛特别的抗氧化色素,集中在视网膜内(黄斑区)可以改变眼球与水晶体的氧化,增加视网膜细胞中视紫质再生成,加强眼睛中的细小血管韧性,也能减少眼睛中的视网膜受到紫外线伤害,以及黄斑色素密度和紫外线单分子对眼睛的损害;
其中,所述蓝莓提取物为花青素,用以增加抗氧化功能和视网膜细胞中视紫质的再生成,减少视网膜剥离和破坏眼部细胞的酵素,同时还有清火、疏通泪腺管、明目亮眼的作用;
其中,虾青素被誉为***抗氧化素,是能穿透血脑屏障和细胞膜,作用于脑细胞和眼球视网膜的一种类胡萝卜素,能减少视网膜的氧化、感光细胞的损伤和紫外线辐射;
其中,玉米黄素和蓝莓提取物的作用相同,是眼睛特别的抗氧化色素,集中在视网膜内(黄斑区)可以改变眼球与水晶体的氧化,增加视网膜细胞中视紫质再生成,加强眼睛中的细小血管韧性,也能减少眼睛中的视网膜受到紫外线伤害,以及黄斑色素密度和紫外线单分子对眼睛的损害;
其中,牛磺酸是视网膜、玻璃体、晶状体、角膜、虹膜和睫状体中丰富的氨基酸,具有调节眼部晶体渗透压、提高感光细胞、减少晶体中的蛋白质氧化等作用,从而可减少白内障的发生;
其中,枸杞多糖可以养护视网膜神经细胞和视神经退行性的发生,能减少肝细胞抗压和增加免疫、减少体内自由基,减少体乏和环境对眼部辐射等作用;
其中,维生素A是构成视网膜感光物质(视紫红质)的重要营养素,对眼睛结膜、角膜和泪腺上皮细胞干燥,泪腺分泌减少导致干眼症有作用;
其中,维生素B族包括有维生素B1和维生素B2;
维生素B1是参与并维持神经(包括视神经)细胞功能和代谢的重要维生素,可减少眼睛干涩、视神经产生氧化、眼球震颤、视觉迟钝症状;
维生素B2是合成机体黄酶类的辅酶所需原料,具有维持角膜、视网膜正常机能和保持眼睛正常视力的作用,以及调养眼结膜和视力模糊、疲劳和减少流泪、眼睛不自主收缩等眼部问题;
维生素C是晶状体的重要营养成分,眼球晶状体中维生素C含量较其它组织高,减少白内障的发生;
其中,维生素E可以有效地增加局部视网膜细胞的营养,并且增加眼表粘膜皮肤的细胞营养,从而保障细胞功能的正常代谢和转运,软化血管,避免眼表以及眼底视网膜血管产生动脉硬化;
其中,酵母粉能改善身体营养不良和缺铁性贫血,并含有非常丰富的蛋白质,可以增进食欲,可用于治疗消化不良、呕吐、痢疾、多发性神经炎、皮肤病等症状;
其中,代乳粉有母乳功能,富含蛋白质和氨基酸,以此补充犬猫营养、达到提高免疫力等作用。
具体的本发明包括以下实施例:
实施例1:
所述保健品包括以下重量份配比的组份:
万寿菊提取物50份、蓝莓提取物15份、虾青素8份、玉米黄素16份、牛磺酸16份、枸杞多糖40份、维生素A7.5份、维生素C3份、维生素E3份、维生素B族6份、酵母粉30份、代乳粉500份。
为进一步说明本保健品的药效,我们对本实施例的保健品效果做了详细的跟踪调查,具体如下:
其中,有效即为眼部状况明显改善,显效即为眼部状况有所改善,无效即为眼部状况没有变化。
实施例2:
所述保健品包括以下重量份配比的组份:
万寿菊提取物60份、蓝莓提取物20份、虾青素10份、玉米黄素20份、牛磺酸20份、枸杞多糖60份、维生素A10份、维生素C5份、维生素E5份、维生素B族10份、酵母粉40份、代乳粉525份。
为进一步说明本保健品的药效,我们对本实施例的保健品效果做了详细的跟踪调查,具体如下:
其中,有效即为眼部状况明显改善,显效即为眼部状况有所改善,无效即为眼部状况没有变化。
实施例3:
所述保健品包括以下重量份配比的组份:
万寿菊提取物65份、蓝莓提取物22份、虾青素12份、玉米黄素25份、牛磺酸23份、枸杞多糖70份、维生素A15份、维生素C8份、维生素E7份、维生素B族12份、酵母粉45份、代乳粉600份。
为进一步说明本保健品的药效,我们对本实施例的保健品效果做了详细的跟踪调查,具体如下:
其中,有效即为眼部状况明显改善,显效即为眼部状况有所改善,无效即为眼部状况没有变化。
综合上述三个实施例,可知,实施例2是本发明最优的一种方案,其能够调养宠物眼睛细胞组织和神经***,减少术后养护和眼部退化性情况的发生,减少眼睛中的水晶体氧化,加强眼睛中的细小血管韧性,调养眼角膜、视神经、视网膜和减少自由基的伤害,减少视网膜氧化和感光细胞的损伤,以及黄斑色素密度和紫外线的影响,调节眼部晶体渗透压、加强感光细胞、减少晶体中的蛋白质氧化等作用,从而可减少眼疾的发生。
实施例4:
本实施例在实施例1的基础上还包括有以下重量份配比的组份:
防腐剂1份、抗氧化剂1份和诱食剂40份。
以上所述,仅为本发明较佳的具体实施方式;但本发明的保护范围并不局限于此。任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其改进构思加以等同替换或改变,都应涵盖在本发明的保护范围内。
Claims (8)
1.一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品至少由万寿菊提取物、蓝莓提取物、虾青素、玉米黄素、牛磺酸、枸杞多糖、维生素A、维生素C、维生素E、维生素B族、酵母粉、代乳粉等组分制成。
2.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品各组份按照以下重量份配比:
万寿菊提取物50份~65份、蓝莓提取物15份~22份、虾青素8份~12份、玉米黄素16份~25份、牛磺酸16份~23份、枸杞多糖40份~70份、维生素A7.5份~15份、维生素C3份~8份、维生素E3份~7份、维生素B族6份~12份、酵母粉30份~45份、代乳粉500份~600份。
3.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品各组份按照以下重量份配比:
万寿菊提取物50份、蓝莓提取物15份、虾青素8份、玉米黄素16份、牛磺酸16份、枸杞多糖40份、维生素A7.5份、维生素C3份、维生素E3份、维生素B族6份、酵母粉30份、代乳粉500份。
4.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品各组份按照以下重量份配比:
万寿菊提取物60份、蓝莓提取物20份、虾青素10份、玉米黄素20份、牛磺酸20份、枸杞多糖60份、维生素A10份、维生素C5份、维生素E5份、维生素B族10份、酵母粉40份、代乳粉525份。
5.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品各组份按照以下重量份配比:
万寿菊提取物65份、蓝莓提取物22份、虾青素12份、玉米黄素25份、牛磺酸23份、枸杞多糖70份、维生素A15份、维生素C8份、维生素E7份、维生素B族12份、酵母粉45份、代乳粉600份。
6.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述蓝莓提取物为花青素。
7.根据权利要求1所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述万寿菊提取物为叶黄素。
8.根据权利要求4所述的一种为犬猫眼部组织提供营养和预防部分眼疾的保健品,其特征在于:所述保健品还包括有以下重量份配比的组份:
防腐剂1份、抗氧化剂1份和诱食剂40份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210025971.6A CN115245528A (zh) | 2022-01-11 | 2022-01-11 | 一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210025971.6A CN115245528A (zh) | 2022-01-11 | 2022-01-11 | 一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115245528A true CN115245528A (zh) | 2022-10-28 |
Family
ID=83698962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210025971.6A Pending CN115245528A (zh) | 2022-01-11 | 2022-01-11 | 一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115245528A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772572A (zh) * | 2012-08-04 | 2012-11-14 | 东莞市照燕生物科技有限公司 | 一种护眼明目的营养保健品 |
CN106617055A (zh) * | 2016-12-13 | 2017-05-10 | 深圳万稞生物科技有限公司 | 一种改善退化性眼疾的护眼保健食品及其制备方法 |
CN109663122A (zh) * | 2019-01-22 | 2019-04-23 | 夏洪峰 | 一种为视网膜黄斑区提供营养、改善视力、预防眼病的组合物颗粒冲剂及其制备方法 |
CN109805400A (zh) * | 2017-11-20 | 2019-05-28 | 威海紫光科技园有限公司 | 一种缓解视疲劳的越橘叶黄素保健食品 |
-
2022
- 2022-01-11 CN CN202210025971.6A patent/CN115245528A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102772572A (zh) * | 2012-08-04 | 2012-11-14 | 东莞市照燕生物科技有限公司 | 一种护眼明目的营养保健品 |
CN106617055A (zh) * | 2016-12-13 | 2017-05-10 | 深圳万稞生物科技有限公司 | 一种改善退化性眼疾的护眼保健食品及其制备方法 |
CN109805400A (zh) * | 2017-11-20 | 2019-05-28 | 威海紫光科技园有限公司 | 一种缓解视疲劳的越橘叶黄素保健食品 |
CN109663122A (zh) * | 2019-01-22 | 2019-04-23 | 夏洪峰 | 一种为视网膜黄斑区提供营养、改善视力、预防眼病的组合物颗粒冲剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McCaa | The eye and visual nervous system: anatomy, physiology and toxicology. | |
CN102144780A (zh) | 一种保护视力的叶黄素酯保健品及其制备方法 | |
JP2008271878A (ja) | 新規飲食品 | |
EP2618832A2 (en) | Composition comprising sod, lutein and zeaxanthin | |
CN104147081A (zh) | 改善视力的蓝莓叶黄素软胶囊及制作方法 | |
Dufier et al. | Ocular changes in long-term evolution of infantile cystinosis | |
CN107837288A (zh) | 一种缓解视疲劳的复方花青素叶黄素酯软胶囊 | |
CN109645201A (zh) | 含有叶黄素和叶黄素酯的组合物、叶黄素压片糖及制备方法和应用 | |
CN102178925A (zh) | 新型视力保护剂叶黄素眼用制剂 | |
CN110496215A (zh) | 一种治疗老视的水性滴眼液及其制备方法 | |
CN104824510A (zh) | 具有视力保护作用的保健食品 | |
CN104824675A (zh) | 视力改善叶黄素胶囊 | |
CN101416741A (zh) | 一种用于缓解视疲劳的保健食品 | |
CN1685888A (zh) | 康视明酸奶片 | |
CN115245528A (zh) | 一种为犬猫眼部组织提供营养和预防部分眼疾的保健品 | |
CN105520137A (zh) | 一种具有缓解视疲劳和保护视力功能的保健食品 | |
CN105412354A (zh) | 黑枸杞护眼棒棒糖 | |
CN1823828A (zh) | 复合维生素复合微量元素防治干眼病药食兼用营养素及制造方法 | |
CN100376235C (zh) | 一种西药组合物在制备治疗玻璃体液化症营养素制品中的应用 | |
CN102526171B (zh) | 预防及延缓老年性黄斑变性功能的眼保健品及制作方法 | |
CN101612161A (zh) | 一种眼药组合物及其制剂 | |
CN110754537A (zh) | 一种防止儿童近视的奶粉及其制备方法 | |
CN1823827A (zh) | 药食兼用西药防治干眼病营养素产品及制造方法 | |
CN1823832A (zh) | 药食两用维生素微量元素防治白内障营养产品及制造方法 | |
CN1823823A (zh) | 药食两用维生素微量元素防治玻璃体液化症营养品及制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20221028 |